Table 3. Frequency of Neovascularization by Treatment Group and by Retinal Location at Baseline.
| Location | Eyes, No. (%) | |
|---|---|---|
| PRP (n = 61) | Aflibercept (n = 59) | |
| Eyes | ||
| With NVD | 26 (42.6) | 16 (27.1) |
| With NVE only | 35 (57.4) | 43 (72.9) |
| Eyes with NVE | ||
| Superior | 20 (32.8) | 22 (37.3) |
| Inferior | 12 (19.7) | 11 (18.6) |
| Nasal | 26 (42.6) | 38 (64.4) |
| Temporal | 16 (26.2) | 18 (30.5) |
| Eyes with NVE with or without NVD | 48 (78.7) | 52 (88.1) |
Abbreviations: NVD, disc neovascularization; NVE, neovascularization elsewhere; PRP, panretinal photocoagulation.